Literature DB >> 3489342

Presence of oestrogen receptors in human blood mononuclear cells and thymocytes.

J J Weusten, M A Blankenstein, F H Gmelig-Meyling, H J Schuurman, L Kater, J H Thijssen.   

Abstract

We studied oestrogen binding sites in blood mononuclear cells from healthy blood donors, patients with leukaemia or systemic lupus erythematosus, and in thymocytes, using the dextran-coated charcoal assay and Scatchard analysis of binding data. Using 3H-labelled oestradiol as ligand, inaccurate results were obtained which could be related to the low amounts of binding sites. Using 125I-labelled ligand, saturable oestradiol binding sites could be demonstrated in low amount (mean value 2.1 fmol/mg of cytosolic protein) and high affinity (mean Kd value 0.26 nM; mean Ka value 3.85 X 10(9) M-1). The binding could be inhibited by unlabelled oestradiol but not with oestrone, dihydrotestosterone, cortisol and the progestin-receptor ligand Org 2058. We conclude that blood mononuclear cells and thymocytes contain true oestrogen receptors. This conclusion supports current hypotheses on the involvement of such receptors in oestrogen-mediated modulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489342     DOI: 10.1530/acta.0.1120409

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  18 in total

Review 1.  Sex differences and estrogen modulation of the cellular immune response after injury.

Authors:  Melanie D Bird; John Karavitis; Elizabeth J Kovacs
Journal:  Cell Immunol       Date:  2008-02-21       Impact factor: 4.868

Review 2.  Estrogen receptors in immunity and autoimmunity.

Authors:  Melissa Cunningham; Gary Gilkeson
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

3.  Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4.

Authors:  H Mori; M Sawairi; N Itoh; T Hanabayashi; T Tamaya
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

4.  Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS.

Authors:  Xiang Y Han; Jeffrey J Tarrand; Rosa Infante; Kalen L Jacobson; Mylene Truong
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control study.

Authors:  Berta Almoguera; Rosa Riveiro-Alvarez; Jorge Lopez-Castroman; Pedro Dorado; Rosario Lopez-Rodriguez; Pablo Fernandez-Navarro; Enrique Baca-García; Jose Fernandez-Piqueras; Rafael Dal-Ré; Francisco Abad-Santos; Adrián Llerena; Carmen Ayuso
Journal:  BMC Med Genet       Date:  2011-06-09       Impact factor: 2.103

6.  Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis.

Authors:  J W Bijlsma; O Huber-Bruning; J H Thijssen
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

7.  T lymphocytes are not the target for estradiol-mediated suppression of DTH in reconstituted female severe combined immunodeficient (SCID) mice.

Authors:  M Taube; L Svensson; H Carlsten
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

Review 8.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

9.  Evidence that granulosa cells inhibit interleukin-1 alpha and interleukin-2 production from follicular lymphomonocytes.

Authors:  A Macciò; G Mantovani; E Turnu; P Artini; G Contu; F G Serri; A Volpe
Journal:  J Assist Reprod Genet       Date:  1993-11       Impact factor: 3.412

10.  A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.

Authors:  G M Hall; M Daniels; E C Huskisson; T D Spector
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.